Peptide Hormones: Therapeutic Targets in Appetite Regulation

Alison M. Wren; Stephen R. Bloom

doi:10.2174/157018006778341219

ISSN: 1570-1808
E-ISSN: 1875-628X

Peptide Hormones: Therapeutic Targets in Appetite Regulation
Authors: Alison M. Wren¹ and Stephen R. Bloom²
View Affiliations Hide Affiliations

¹ Department of Metabolic Medicine, Imperial College London, 6th Floor Commonwealth Building,Hammersmith Hospital, Du Cane Road, London W12 0NN, UK. ² Department of Metabolic Medicine, Imperial College London, 6th Floor Commonwealth Building,Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.
Source: Letters in Drug Design & Discovery, Volume 3, Issue 9, Nov 2006, p. 593 - 597
DOI: https://doi.org/10.2174/157018006778341219
- Available online: 01 Nov 2006

Abstract

Recent studies have identified a novel role for gut-derived peptides in the physiological regulation of appetite and body weight. This data is reviewed and the potential of peptide hormones, particularly ghrelin, PYY, GLP-1 and oxyntomodulin, as therapies for anorexia and obesity is explored.

Article metrics loading...

/content/journals/lddd/10.2174/157018006778341219

2006-11-01

2025-09-25

From This Site

/content/journals/lddd/10.2174/157018006778341219

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Full text loading...

/content/journals/lddd/10.2174/157018006778341219

Article Type: Research Article

Keyword(s): Anorexia; Ghrelin; Gut hormones; Obesity; Oxyntomodulin; PYY

Peptide Hormones: Therapeutic Targets in Appetite Regulation

Abstract

From This Site

Most Read This Month

Most Cited Most Cited RSS feed

Discovery, Structural Determination and Anticancer Activities of Lactucinlike Guaianolides

Thermodynamic Aspects of Cancer: Possible Role of Negative Entropy in Tumor Growth, its Relation to Kinetic and Genetic Resistance

Immunomodulatory Properties of Synthetic Imidazolone Derivatives

Design and Prediction of ADME/Tox Properties of Novel Magnolol Derivatives as Anticancer Agents for NSCLC Using 3D-QSAR, Molecular Docking, MOLCAD and MM-GBSA Studies

Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease

Identifying Protein Binding Sites and Optimal Ligands

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part II: Sulfonamides

Selection of a Catalytically Active Enzyme In Vivo Via Phage Display of its Product

A Comprehensive Review of the Advancement in Omic Technologies in the Field of Drug Discovery and Development